Pulmonary hypertension in heart failure with preserved ejection fraction: the TOPCAT Americas and PARAGON-HF studies

Back

HFA Premium Access

Pulmonary hypertension in heart failure with preserved ejection fraction: the TOPCAT Americas and PARAGON-HF studies

Session: Chronic Heart Failure - Pathophysiology and Mechanisms 1

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor K. Jering (Boston, US)

Event: Heart Failure 2021

Congress Presentation

Add to my library

About the speaker

Doctor Karola Jering

Brigham and Women's Hospital, Boston (United States of America)

0 follower

9 more presentations in this session

Real world analysis of outcomes of remote pulmonary artery hemodynamic monitoring in overweight and obese patients with heart failure

Speaker: Doctor M. Oberoi (Sioux Falls, US)

Multicenter nationwide study of the prevalence of ATTR-CM in HFpEF in Spain. Intermediate results from national PRACTICA study.

Speaker: Doctor J. Garcia-Pinilla (Malaga, ES)

HDAC6 inhibition improves diastolic function in a mouse model of heart failure with preserved ejection fraction

Speaker: Mr J. Yang (South San Francisco, US)

Changes in natriuretic peptide and effects of vericiguat in worsening heart failure with reduced ejection fraction: Insights from VICTORIA (VerICiguaT Global Study in Subjects with HFrEF)

Speaker: Doctor J. Ezekowitz (Edmonton, CA)

Initiation of sacubitril/valsartan in patients with renal impairment early after acute decompensated heart failure in the TRANSITION study

Speaker: Professor E. Straburzynska-Migaj (Poznan, PL)

Access the full session

Chronic Heart Failure - Pathophysiology and Mechanisms 1

Speakers: Doctor K. Jering, Doctor M. Oberoi, Doctor J. Garcia-Pinilla, Mr J. Yang, Doctor J. Ezekowitz...

Access

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources